B. Metzler seel. Sohn & Co. AG Purchases Shares of 8,029 Humana Inc. $HUM

Key Points

• B. Metzler seel. Sohn & Co. AG initiated a position in Humana by purchasing 8,029 shares valued at approximately $3.19 million during the second quarter. Other institutional investors also added stakes, with institutions and hedge funds owning 92.38% of the stock.
• Humana reported quarterly earnings of $7.61 per share, exceeding estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion.
• Analyst sentiment remains mixed: 14 analysts rate the stock a Buy, 15 a Hold, and one a Sell, resulting in an average “Hold” rating and an average price target of $395.22.

B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 8,029 shares of the insurance provider's stock, valued at approximately $3,189,000.

Several other hedge funds have also bought and sold shares of the company. Trillium Asset Management LLC bought a new position in Humana during the second quarter worth $508,000. Vise Technologies Inc. acquired a new position in shares of Humana in the second quarter valued at $978,000. OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Humana in the second quarter valued at about $240,000. E Fund Management Co. Ltd. bought a new position in shares of Humana in the second quarter valued at about $504,000. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Humana during the 2nd quarter worth about $26,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE HUM opened at $379.22 on Friday. The stock has a market capitalization of $45.54 billion, a PE ratio of 35.88, a P/E/G ratio of 2.17 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The business has a fifty day moving average price of $383.38 and a two-hundred day moving average price of $281.59. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the firm posted $6.27 EPS. Humana's quarterly revenue was up 26.2% on a year-over-year basis. As a group, equities analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. The Goldman Sachs Group upped their target price on Humana from $158.00 to $195.00 and gave the company a "sell" rating in a research report on Thursday, April 30th. Royal Bank Of Canada lifted their price target on Humana from $246.00 to $415.00 and gave the stock a "sector perform" rating in a report on Thursday, July 9th. Jefferies Financial Group upgraded Humana from a "buy" rating to a "buy" rating in a research note on Wednesday, May 20th. Robert W. Baird set a $390.00 price objective on Humana in a report on Thursday, July 30th. Finally, Truist Financial increased their price objective on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Humana currently has an average rating of "Hold" and an average price target of $395.22.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source